PharmaOPS.BXL

Active

Private limited companyfounded 2023active for 3 yearsZavelput 17, 1000 Brussel, BelgiumKBO/BCE: BE 0804.644.494

Summary

The computed 12-month bankruptcy probability of PharmaOPS.BXL is 15.2% (high). The 2024 annual accounts show equity of €6,268 and a net result of €5,268. Its solvency ranks better than 10% of 9,537 sector peers (NACE 47, financial year 2024). The company has been active since 2023 and the Belgian Official Gazette contains no insolvency or warning signals.

Risk analysisFollow Report Compare

PharmaOPS.BXLActiveChecked score 30/100

Risk analysis Report Compare

History

PharmaOPS.BXL was incorporated on 17 August 2023 as a private limited company by PHARMABXL, PHARMALEGAL and three other companies, with a starting capital of €1,000.¹² The registered office was moved to Bruxelles in 2026.³ Since 2025, Georges DE FEU has served as director of the company.⁴

Acts, filings and financial milestones

All 7Financial 1Gazette 4Filings 2

2026

01-07

Gazette deed Registered office

Registered-office move2 facts ▸

Board meeting, 01-06-2026
Registered-office move, Zavelput 17,1000 BRUXELLES

13-04

Gazette deed Resignation: PharmaBXL (director)

Permanent representative: Georges DE FEU3 facts ▸

General meeting, 13-02-2026
Director resignation, PharmaBXL (director)
Permanent representative, Georges DE FEU

2025

12-11

Gazette deed Appointment: Georges DE FEU (director)

4 facts ▸

General meeting, 01-10-2025
Director appointment, Georges DE FEU (director)
Board meeting, 01-10-2025
Board composition, Georges DE FEU (director)

30-09

NBB filing Annual accounts filed

financial year 2024 · abbreviated format · 61 days late

2024

31-12

Financial Back to profitnet €5,268

Net result €5,268 after one loss-making year.

06-08

NBB filing Annual accounts filed

financial year 2023 · abbreviated format · 6 days late

2023

21-08

Gazette deed Incorporation

Appointment: PHARMABXL (statutory director) · Permanent representatives: OLBRECHTS Olivier Ivan Valéry and DE FEU Georges · Founder13 facts ▸

Incorporation, “PharmaOPS.BXL” (deed in French)
Founder, PHARMABXL
Founder, PHARMALEGAL
Founder, FILIP GILIAS
Founder, REMEDIA
Founder, O2C
Founding capital, €1,000
Bank account, “Crelan SA, notaire pour garder dans dossier” (deed in French)
Capital
Director appointment, PHARMABXL (statutory director)
Permanent representative, OLBRECHTS Olivier Ivan Valéry
Permanent representative, DE FEU Georges (représentant permanent suppléant)
+1 further fact in this act

Financial milestoneGazette deedNBB filingFinancial milestones sit on the financial year-end date, not the filing date.

4 of 4 deeds read